News
Colgate-Palmolive (India) experienced a nearly 7% decline after a weak March quarter, impacted by flat sales volume and urban ...
Colgate-Palmolive's Hill’s Pet Nutrition segment is a key growth driver, benefiting from rising pet ownership. See why CL ...
Piper Sandler reiterated its $109 price target and Overweight rating on Colgate-Palmolive Company (NYSE:CL) on May 28. The ...
8d
Zacks.com on MSNColgate to Aid by Innovation & Other Efforts: Should You Buy or Hold?CL gains from strong pricing, productivity moves, and an innovation strategy that supports continued momentum.
Colgate-Palmolive recently introduced its new toothpaste, Colgate Total Active Prevention, to the Jamaican market, featuring ...
Shares of Colgate-Palmolive (India) fell nearly 6 per cent after it posted a 6.5 per cent decline in its net profit ...
The fact that multiple Colgate-Palmolive Company ( NYSE:CL ) insiders offloaded a considerable amount of shares ...
India’s largest listed oral care company, Colgate-Palmolive (India), undershot even the modest expectations of the Street in ...
Management attributed Q4 weak earnings to softening urban demand and heightened competition in the personal care and oral ...
Goldman Sachs went on to warn that the current competitive environment in the oral care business is likely to strain ...
The downturn in Colgate Palmolive (India)'s stock, coupled with high trading volumes, reflects a notable shift in investor ...
Colgate Palmolive reports Rs. 355 crore net profit in Q4, anticipates market recovery, focuses on innovation and growth.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results